You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IL (interleukin)

Showing 1 - 25 of 6,892
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer Trial in Houston (Interleukin-2, Placebo)

Recruiting
  • Alzheimer Disease
  • Houston, Texas
    Houston Methodist Research Institute
Oct 17, 2023

Periodontitis Trial in Rize (biochemical analysis)

Completed
  • Periodontitis
  • biochemical analysis
  • Rize, Turkey
    Recep Tayyip Erdogan University
Oct 18, 2023

Interleukin (IL) -35 in Mycosis Fungoides:Case Control Study

Recruiting
  • Mycosis Fungoides
  • Skin biopsy
  • Giza, Egypt
    Cairo University
May 3, 2023

Non-Eosinophilic Biological Effects of IL-5

Not yet recruiting
  • Asthma
    • (no location specified)
    Sep 6, 2023

    Autoantibodies, Interleukin-6 Trial in Frederiksberg (Oral Glucose Tolerance Test, Cycling test)

    Recruiting
    • Autoantibodies
    • Interleukin-6
    • Oral Glucose Tolerance Test
    • Cycling test
    • Frederiksberg, Denmark
      Frederiksberg Hospital
    May 10, 2023

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023

    Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

    Not yet recruiting
    • Pancreatic Cancer
    • +3 more
    • Histamine Dihydrochloride (HDC)
    • Interleukin-2 (IL-2)
    • (no location specified)
    Mar 31, 2023

    HIV Infection Trial in Cleveland (Recombinant Interleukin-2)

    Terminated
    Has Results
    • HIV Infection
    • Recombinant Interleukin-2
    • Cleveland, Ohio
      AIDS Clinical Trials Unit
    Sep 1, 2022

    Alzheimer Trial in Houston (Aldesleukin)

    Completed
    • Alzheimer Disease
    • Houston, Texas
      Alireza Faridar
    Apr 19, 2023

    Sjögren's Syndrome Trial in Beijing (low-dose interleukin-2, rapamycin)

    Recruiting
    • Sjögren's Syndrome
    • Beijing, Beijing, China
      Peking university people's hospital
    Dec 2, 2022

    TIA, Carotid Artery Plaque, Carotid Atherosclerosis Trial in Cambridge (Interleukin-2 [IL-2], Standard care - Carotid

    Not yet recruiting
    • TIA
    • +2 more
    • Interleukin-2 [IL-2]
    • Standard care - Carotid Endarterectomy
    • Cambridge, Cambridgeshire, United Kingdom
      Addenbrookes Hospital
    Aug 2, 2023

    Early Disease Onset Trial (Puva (psoralin and uva ))

    Not yet recruiting
    • Early Disease Onset
    • Puva (psoralin and uva )
    • (no location specified)
    Sep 27, 2023

    Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Proleukin 1.3 MG Injection
    • (no location specified)
    Apr 6, 2023

    Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

    Completed
    • Pleural Mesothelioma
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)

    Recruiting
    • Leiomyosarcoma
    • Dinutuximab Beta, Zoledronic acid, Interleukin-2
    • Bad Saarow, Germany
    • +1 more
    Jun 2, 2022

    IL-5R Signaling in Non-eosinophil Upper Airway Cells in CRSwNP

    Recruiting
    • Nasal Polyps
    • Aspirin-exacerbated Respiratory Disease
    • Non-Interventional
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jan 5, 2023

    Active Non Segmental Vitiligo Trial in Cairo (Narrow band ultraviolet B)

    Completed
    • Active Non Segmental Vitiligo
    • Narrow band ultraviolet B
    • Cairo, Helwan, Egypt
      Nourhan Emad
    Aug 8, 2022

    A Biomarker Predicating Early Onset Neonatal Sepsis

    Recruiting
    • Neonatal Sepsis, Early-Onset
    • IL27, PCT, CRP, Blood culture
    • Abu Dhabi, United Arab Emirates
      Mansoura University Children Hospital
    Oct 18, 2022

    Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

    Not yet recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +3 more
    • Biospecimen Collection
    • +8 more
    • Kansas City, Kansas
      University of Kansas Cancer Center
    Nov 27, 2023

    Idiopathic Subglottic Stenosis Trial in New Haven (Taltz)

    Not yet recruiting
    • Idiopathic Subglottic Stenosis
    • New Haven, Connecticut
      Yale New Haven Hospital
    Jul 21, 2022

    Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

    Active, not recruiting
    Has Results
    • Kidney Cancer
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jun 21, 2022

    Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

    Completed
    Has Results
    • Adult T-Cell Lymphoma/Leukemia
    • +2 more
    • Recombinant human Interleukin-15 (rhIL-15)
    • Mogamulizumab
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 9, 2022

    Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

    Recruiting
    • Metastatic Melanoma
    • +9 more
    • TBio-4101
    • +3 more
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 24, 2023

    Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Stage IVA Lung Cancer AJCC v8 Trial in Atlanta (Aldesleukin,

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • +3 more
    • Aldesleukin
    • Pembrolizumab
    • Atlanta, Georgia
      Emory University/Winship Cancer Institute
    Aug 8, 2022

    Renal Cell Carcinoma Trial in Portland (High Dose IL-2, SBRT)

    Active, not recruiting
    • Renal Cell Carcinoma
    • High Dose IL-2
    • SBRT
    • Portland, Oregon
      Portland Providence Medical Center
    Jan 31, 2022